COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Spyral HTN off med

Purpose of Study

To test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the absence of antihypertensive medications

Trial Status

In follow up

Eligibility Criteria

Age 20-80 years old, willing to discontinue current antihypertensive meds between the 1st screening visit and post procedure visit at 3 months, office systolic blood pressure > 140 mmHg and < 170 mmHg, office diastolic blood pressure >90 mmHg

Duration of Participation

Approximately 3 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: jyoung@iowaheart.com